Zurcher Kantonalbank Zurich Cantonalbank raised its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 21.9% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 141,635 shares of the company's stock after acquiring an additional 25,461 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank's holdings in GE HealthCare Technologies were worth $11,617,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also bought and sold shares of the company. Temasek Holdings Private Ltd purchased a new position in shares of GE HealthCare Technologies during the third quarter valued at approximately $99,922,000. Valicenti Advisory Services Inc. lifted its position in shares of GE HealthCare Technologies by 22.6% during the third quarter. Valicenti Advisory Services Inc. now owns 68,107 shares of the company's stock worth $5,115,000 after purchasing an additional 12,550 shares during the last quarter. Locust Wood Capital Advisers LLC lifted its position in shares of GE HealthCare Technologies by 7.1% during the third quarter. Locust Wood Capital Advisers LLC now owns 2,084,337 shares of the company's stock worth $156,534,000 after purchasing an additional 137,992 shares during the last quarter. Nan Fung Trinity HK Ltd. bought a new stake in shares of GE HealthCare Technologies during the third quarter worth $23,206,000. Finally, Envestnet Asset Management Inc. lifted its position in shares of GE HealthCare Technologies by 15.8% during the third quarter. Envestnet Asset Management Inc. now owns 338,914 shares of the company's stock worth $25,452,000 after purchasing an additional 46,231 shares during the last quarter. Institutional investors own 82.06% of the company's stock.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on GEHC shares. Wells Fargo & Company lifted their target price on GE HealthCare Technologies from $95.00 to $97.00 and gave the stock an "overweight" rating in a research report on Thursday, February 5th. Weiss Ratings reaffirmed a "hold (c+)" rating on shares of GE HealthCare Technologies in a research report on Monday, December 29th. Piper Sandler reduced their target price on shares of GE HealthCare Technologies from $96.00 to $88.00 and set an "overweight" rating on the stock in a research report on Friday, April 17th. Stifel Nicolaus raised their target price on shares of GE HealthCare Technologies from $95.00 to $98.00 and gave the stock a "buy" rating in a research report on Wednesday, February 4th. Finally, Wall Street Zen lowered shares of GE HealthCare Technologies from a "buy" rating to a "hold" rating in a research report on Saturday, March 21st. Eight research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Hold" and a consensus target price of $89.77.
Read Our Latest Report on GE HealthCare Technologies
GE HealthCare Technologies Stock Performance
Shares of GEHC opened at $69.89 on Friday. The stock has a market cap of $31.89 billion, a P/E ratio of 15.33, a P/E/G ratio of 1.57 and a beta of 1.17. GE HealthCare Technologies Inc. has a one year low of $64.77 and a one year high of $89.77. The stock has a 50-day moving average of $74.88 and a two-hundred day moving average of $77.82. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.37.
GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last posted its quarterly earnings data on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.04. The business had revenue of $5.70 billion during the quarter, compared to analysts' expectations of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business's revenue was up 7.1% compared to the same quarter last year. During the same period in the previous year, the business earned $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 5 EPS for the current year.
GE HealthCare Technologies Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Stockholders of record on Friday, April 3rd will be given a $0.035 dividend. The ex-dividend date is Thursday, April 2nd. This represents a $0.14 annualized dividend and a dividend yield of 0.2%. GE HealthCare Technologies's dividend payout ratio (DPR) is 3.07%.
GE HealthCare Technologies Company Profile
(
Free Report)
GE HealthCare Technologies NASDAQ: GEHC is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.
In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.
Featured Stories
Want to see what other hedge funds are holding GEHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider GE HealthCare Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and GE HealthCare Technologies wasn't on the list.
While GE HealthCare Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Click the link to see our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.